SCHEMBL14560436

SCHEMBL14560436

CCCCCCN1C(=O)C(=O)N(Cc2ccccc2)C1=O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.59
KDM4E B2RXH2 1/20 0.59
MEN1 O00255 1/20 0.59
USP2 O75604 1/20 0.59
POLB P06746 1/20 0.59
MAPT P10636 1/20 0.59
RECQL P46063 1/20 0.59
BLM P54132 1/20 0.59
F2 P00734 1/20 0.55
PLG P00747 1/20 0.55
ELANE P08246 1/20 0.55
CTSG P08311 1/20 0.55
CMA1 P23946 1/20 0.55
CTRC Q99895 1/20 0.55
CDC25A P30304 3/20 0.50
CES1 P23141 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14560433 0.94 ELANE (0.58) KMT2AKDM4EMEN1USP2POLB
SCHEMBL3422902 0.84 MEN1 (0.86) KMT2AKDM4EMEN1USP2POLB
SCHEMBL23440029 0.82 F2 (0.60) KMT2AKDM4EMEN1USP2POLB
SCHEMBL28256798 0.81 MGLL (0.69) KMT2AKDM4EMEN1USP2POLB
SCHEMBL13793073 0.81 ELANE (0.82) KMT2AMEN1MAPTF2PLG
SCHEMBL20673341 0.78 F2 (0.64) KMT2AKDM4EMEN1USP2MAPT
SCHEMBL14560444 0.78 CYP19A1 (0.42) KMT2AKDM4EMEN1USP2POLB
SCHEMBL3419510 0.77 KMT2A (0.80) KMT2AKDM4EMEN1USP2POLB
SCHEMBL14560437 0.77 AGTR1 (0.49) KMT2AMEN1USP2POLBMAPT
SCHEMBL732925 0.76 CES1 (0.68) KMT2AMEN1CDC25ACES1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7192967-B1 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents ASTELLAS PHARMA GMBH (DE) 2007-03-20 US disclosed